Media/Policy Watch
This section is intended to alert readers to substantive news, analysis and opinion from the general media on vaccines, immunization, global; public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.

We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 12 March 2016
The Rare Super-Antibodies That Destroy HIV
A recent study sheds new light on a rare immune response to the virus—and could bring researchers a step closer to developing a vaccine.
Diana Crow – Mar 10, 2016

.

BBC
http://www.bbc.co.uk/
Accessed 12 March 2016
Would you take a dose of hookworms?
13 Mar 2016
…Scientists in Washington are infecting healthy volunteers with hookworms to help the development of a vaccine against the parasite that can cause severe disability and anaemia. Lizzie Crouch reports…

.

Financial Times
http://www.ft.com/home/uk
Accessed 12 March 2016
WHO chief wants help for drug industry to fight global pandemics
7 March 2016
…Pharmaceuticals companies cannot be expected to keep picking up the bill for tackling global pandemics, the head of the World Health Organisation has warned, urging the creation of a new funding mechanism for emergency drugs and vaccines. Margaret Chan, WHO director-general, said the pharma industry had spent almost $1bn developing Ebola vaccines in the past two years without any return on investment. … “We need a funding mechanism in place allowing countries and industry to prepare for high-impact events.” …

.

The Guardian
http://www.guardiannews.com/
Accessed 12 March 2016
Ebola vaccine trial in Sierra Leone battles against fear and logistics
Health workers face suspicion and a lack of cold storage as they test the Ebola vaccine and also try to reach children who have missed inoculations against other diseases
10 March 2016

.

New York Times
http://www.nytimes.com/
Accessed 12 March 2016
MSF Challenges Pfizer’s India Vaccine Patent Application
NEW DELHI — Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organizations.
March 12, 2016 – By THE ASSOCIATED PRESS –

Brazil Giving $2.8 Million for Zika Research
Health Minister Marcelo Castro said over a $1 million would help finance a study to find a vaccine for the virus, which Brazilian researchers have tentatively linked to a surge in cases of microcephaly,
March 10, 2016 – By THE ASSOCIATED PRESS – World –

.

Wall Street Journal
http://online.wsj.com/home-page?_wsjregion=na,us&_homepage=/home/us
Accessed 12 March 2016
Mind and Matter: Susan Pinker
The Peril of Ignoring Vaccines—and a Solution